Daniel J. Buzard

1.0k total citations
19 papers, 733 citations indexed

About

Daniel J. Buzard is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Daniel J. Buzard has authored 19 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 7 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Daniel J. Buzard's work include Catalytic Cross-Coupling Reactions (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Synthesis and Catalysis (3 papers). Daniel J. Buzard is often cited by papers focused on Catalytic Cross-Coupling Reactions (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Synthesis and Catalysis (3 papers). Daniel J. Buzard collaborates with scholars based in United States. Daniel J. Buzard's co-authors include Robert M. Jones, Bruce H. Lipshutz, Juerg Lehmann, Jayant Thatte, Sangdon Han, James Leonard, Mariangela Urbano, Eduardo J. E. Caro‐Diaz, Mark G. Charest and Andrew G. Myers and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Daniel J. Buzard

19 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Buzard United States 15 387 277 130 117 88 19 733
Gloria Hernández‐Torres Spain 16 1.0k 2.6× 221 0.8× 218 1.7× 74 0.6× 37 0.4× 22 1.3k
Yasuhiro Yonetoku Japan 12 200 0.5× 200 0.7× 30 0.2× 67 0.6× 139 1.6× 20 491
Antonio Navarro Spain 19 494 1.3× 447 1.6× 70 0.5× 130 1.1× 14 0.2× 38 968
Zhaoxing Meng China 12 310 0.8× 147 0.5× 304 2.3× 171 1.5× 39 0.4× 20 705
Takuya Okada Japan 17 390 1.0× 319 1.2× 48 0.4× 73 0.6× 32 0.4× 72 827
Wen‐Lian Wu United States 15 479 1.2× 243 0.9× 47 0.4× 101 0.9× 33 0.4× 38 747
John P. Yardley United States 15 391 1.0× 295 1.1× 62 0.5× 68 0.6× 112 1.3× 33 898
A. Michael Crider United States 17 542 1.4× 378 1.4× 159 1.2× 155 1.3× 27 0.3× 55 1.0k
Minoru Moriya Japan 18 564 1.5× 281 1.0× 105 0.8× 88 0.8× 24 0.3× 40 1.1k
Brian A. Stearns United States 15 581 1.5× 154 0.6× 92 0.7× 64 0.5× 28 0.3× 24 937

Countries citing papers authored by Daniel J. Buzard

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Buzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Buzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Buzard more than expected).

Fields of papers citing papers by Daniel J. Buzard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Buzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Buzard. The network helps show where Daniel J. Buzard may publish in the future.

Co-authorship network of co-authors of Daniel J. Buzard

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Buzard. A scholar is included among the top collaborators of Daniel J. Buzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Buzard. Daniel J. Buzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Caro‐Diaz, Eduardo J. E., Mariangela Urbano, Daniel J. Buzard, & Robert M. Jones. (2016). C–H activation reactions as useful tools for medicinal chemists. Bioorganic & Medicinal Chemistry Letters. 26(22). 5378–5383. 66 indexed citations
2.
Sengupta, Dipanjan, Tawfik Gharbaoui, Daniel J. Buzard, et al.. (2015). An Efficient Scale-Up Process for the Preparation of the APD334 Precursor 4-Chloromethyl-1-cyclopentyl-2-(trifluoromethyl)benzene. Organic Process Research & Development. 19(6). 618–623. 7 indexed citations
3.
Buzard, Daniel J., Thomas O. Schrader, Xiuwen Zhu, et al.. (2014). Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor. Bioorganic & Medicinal Chemistry Letters. 25(3). 659–663. 13 indexed citations
4.
Unett, David J., Joel Gatlin, Todd L. Anthony, et al.. (2013). Kinetics of 5-HT2B Receptor Signaling: Profound Agonist-Dependent Effects on Signaling Onset and Duration. Journal of Pharmacology and Experimental Therapeutics. 347(3). 645–659. 45 indexed citations
5.
Han, Sangdon, Jayant Thatte, Daniel J. Buzard, & Robert M. Jones. (2013). Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists. Journal of Medicinal Chemistry. 56(21). 8224–8256. 115 indexed citations
6.
Buzard, Daniel J., Juerg Lehmann, Sangdon Han, & Robert M. Jones. (2012). GPR119 Agonists 2009–2011. Pharmaceutical Patent Analyst. 1(3). 285–299. 8 indexed citations
7.
Schrader, Thomas O., Benjamin Johnson, Tawfik Gharbaoui, et al.. (2012). Complementary Asymmetric Routes to (R)-2-(7-Hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate. Organic Letters. 14(24). 6306–6309. 31 indexed citations
8.
Savall, Brad M., James P. Edwards, Jennifer D. Venable, et al.. (2010). Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(11). 3367–3371. 18 indexed citations
9.
Jones, Robert M., James Leonard, Daniel J. Buzard, & Juerg Lehmann. (2009). GPR119 agonists for the treatment of type 2 diabetes. Expert Opinion on Therapeutic Patents. 19(10). 1339–1359. 124 indexed citations
10.
Buzard, Daniel J., Jayant Thatte, Michael R. Lerner, Jeffrey E. Edwards, & Robert M. Jones. (2008). Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders. Expert Opinion on Therapeutic Patents. 18(10). 1141–1159. 16 indexed citations
11.
Arienti, Kristen L., Daniel J. Buzard, Michael D. Hack, et al.. (2006). Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(23). 6043–6048. 38 indexed citations
12.
Lipshutz, Bruce H., Daniel J. Buzard, Christina Olsson, & Kevin Noson. (2004). A modular route to nonracemic cyclo-NOBINs. Preparation of the parent ligand for homo- and heterogeneous catalysis. Tetrahedron. 60(20). 4443–4449. 16 indexed citations
13.
14.
15.
Lipshutz, Bruce H., John M. Keith, & Daniel J. Buzard. (1999). An Electrospray Ionization Mass Spectrometry Study of the Aggregation States of Organocopper Complexes in Solution. Organometallics. 18(9). 1571–1574. 49 indexed citations
16.
17.
Lipshutz, Bruce H., et al.. (1998). A New Bromo Trienyne:  Synthesis of all-E, Conjugated Tetra-, Penta-, and Hexaenes Common to Oxo Polyene Macrolide Antibiotics. The Journal of Organic Chemistry. 63(18). 6092–6093. 28 indexed citations
18.
Lipshutz, Bruce H., et al.. (1997). Cuprate‐catalyzed Three‐Component Couplings of Functionalized Organozinc Reagents. Journal of the Chinese Chemical Society. 44(1). 1–4. 2 indexed citations
19.
Lipshutz, Bruce H., et al.. (1997). Alkylations of Functionalized Organozinc Reagents with Allylic EpoxidesCatalyzedby A Cyanocuprate. Synlett. 1997(Sup. I). 477–478. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gloria Hernández‐Torres Breakdown of academic impact, for papers by Yasuhiro Yonetoku Breakdown of academic impact, for papers by Antonio Navarro Breakdown of academic impact, for papers by Zhaoxing Meng Breakdown of academic impact, for papers by Takuya Okada Breakdown of academic impact, for papers by Wen‐Lian Wu Breakdown of academic impact, for papers by John P. Yardley Breakdown of academic impact, for papers by A. Michael Crider Breakdown of academic impact, for papers by Minoru Moriya Breakdown of academic impact, for papers by Brian A. Stearns
Rankless by CCL
2026